問卷
Log In
繁中 EN
TPIDB
TPIDB Outstanding PI
TPIDB > Search Result

Search Result

篩選

Developmental Phase

  • Phase I

  • Phase I/II

  • Phase II

  • Phase II/III

  • Phase III

  • Phase IV

  • Others

Trial Status

  • Not yet recruiting

  • Active

  • Completed

Recruitment Status

  • Not yet recruiting

  • Recruiting

  • Completed

  • Terminated

  • Stop recruiting

  • Suspended

  • Study ended

Trial scale

  • Multi-Regional Multi-Center

  • Taiwan Multiple Center

  • Taiwan Single Center

The expected start time interval of the test

-

Trial Applicant

  • Hospital/Foundation

  • Pharmaceutical/Biopharmaceutical company

  • Contract Research Organization

Important Roles

  • Asia Regional PI

  • Taiwan National PI

  • Chairman/Global PI

  • Steering Committee

  • Advisory board

  • None

Audit by Sponsors/CRO

  • Sponsors

  • CRO

  • None

Investigator-initiated trial(IIT)

  • Yes

Filters

Study Statistics

5316Cases

20022027

Total

5316

  • I

    573

  • I/II

    251

  • II

    1225

  • II/III

    138

  • III

    2607

  • IV

    105

  • Others

    356

Principal Investigator

2769Doctors

Co-Principal Investigator

8934Doctors

Hospital

125Sites

List

5316Cases

2023-01-16 - 2025-08-30

Phase III

Completed
-

  • Condition/Disease

    -

  • Test Drug

    -

Participate Sites
23Sites

Recruiting13Sites

Terminated5Sites

2026-06-01 - 2028-12-31

Phase II

Not yet recruiting
A two-part Phase IIb randomized, multicenter, open-label comparative study to firstly evaluate the safety and efficacy trial of BV100 in combination with low dose polymyxin B plus ceftazidime/avibactam, or plus cefiderocol versus best available therapy in patients with hospital-acquired bacterial pneumonia, ventilator-associated bacterial pneumonia and bloodstream infection, suspected or confirmed to be due to carbapenem-resistant Acinetobacter baumannii calcoaceticus complex (CRABC), and secondly to evaluate the pharmacokinetics of BV100 in combination with low dose polymyxin B plus cefiderocol in patients with confirmed CRABC ventriculitis or meningitis.

  • Condition/Disease

    Ventilator Associated Bacterial Pneumonia (VABP) Hospital Acquired Bacterial Pneumonia (HABP) Blood Stream Infection Meningitis, Bacterial Ventriculitis, Infectious

  • Test Drug

    Aztreonam BV100 FETROJA Polymyxin B Zavicefta

Participate Sites
9Sites

Not yet recruiting1Sites

2026-06-16 - 2031-09-30

Phase II

Not yet recruiting
A Phase 2, Open-Label Study to Evaluate the Safety and Efficacy of Intravesical Instillation of TARA-002 in Adults with High-Grade Non-Muscle Invasive Bladder Cancer

  • Condition/Disease

    Non-muscle Invasive Bladder Cancer

  • Test Drug

    TARA-002

Participate Sites
4Sites

Not yet recruiting4Sites

2026-04-20 - 2034-12-31

Phase II/III

Not yet recruiting
A Phase 2/3 randomized, open-label study of MK-1045 in combination with rituximab in participants with 1L follicular lymphoma

  • Condition/Disease

    Follicular Lymphoma

  • Test Drug

    MK-1045 Rituximab

Participate Sites
2Sites

Not yet recruiting2Sites

2024-12-01 - 2028-01-31

Phase III

Active
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study with an Open-Label Extension to Evaluate the Efficacy, Safety, and Tolerability of Atogepant for the Preventive Treatment of Menstrual Migraine

  • Condition/Disease

    Menstrual Migraine (MM)

  • Test Drug

    Atogepant

Participate Sites
5Sites

Recruiting5Sites

聯絡我們

台灣臨床試驗主持人資料庫 TPIDB

All Contents Copyright 2020 台灣臨床試驗主持人資料庫TPIDB